OptiNose, Inc.: Financial Report Reveals Stability
OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
- Latest
- Trending
OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
Discover the financial report of Workhorse Group Inc. (WKHS), a technology company specializing in zero-emission commercial vehicles. Despite revenue growth, ...
Discover detailed financial analysis and stock price prediction of Apple Inc. (AAPL). With strong revenue growth and profitability, the stock ...
Explore the financial report of Fresh Del Monte Produce Inc. (FDP) for insightful analysis and stock price prediction. Discover key ...
Explore the financial potential of Slam Corp., a shell company in New York seeking merger or acquisition opportunities. Stay informed ...
Discover the financial snapshot of CorVel Corporation in the insurance brokers industry. Explore key metrics, industry analysis, stock performance, and ...
AI investors' must-own list includes Berkshire Hathaway, Danaher, and another undisclosed holding. These investments account for a significant portion of ...
Oddity Tech, the Israeli digital consumer tech platform for beauty and wellness, exceeded Q4 estimates and provided positive guidance for ...
GitLab expects lower adjusted earnings for fiscal 2025, while Target's fourth-quarter earnings exceeded estimates. AeroVironment reported strong fiscal third-quarter earnings, ...
Spirent Communications experienced a decline in pretax profit and revenue due to challenging market conditions, though gross margin improved.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.